Nutritional chemoprevention of Urinary Tract Tumors (UTT) induced by lithogenic agents: Risk for UTT in children exposed to melamine-contaminated milk formulas

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 30, Issue 2, 2012, Pages 174-187

  Vara Messler, M ^a,b   Cremonezzi, D C ^a,b   Soria, E A ^a,c   Eynard, Aldo R ^a,c  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^b Universidad Nacional de Córdoba   (Argentina)

^c NONE   (Argentina)

Author keywords

Cancer; Chronic inflammation; Melamine; Polyunsaturated fatty acid; Toxicology; Urinary tract tumors

Indexed keywords

CANCER; CARCINOGENIC POTENTIAL; CHEMOPREVENTION; CHRONIC INFLAMMATION; CHRONIC INFLAMMATORY; CONTAMINATED MILK; EXPERIMENTAL EVIDENCE; LOW CONCENTRATIONS; TOXICOLOGY; URINARY TRACT;

DISEASES; MAMMALS; MELAMINE; PATHOLOGY; POLYUNSATURATED FATTY ACIDS;

TUMORS;

CARCINOGEN; MELAMINE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OMEGA 9 FATTY ACID; POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

ARTIFICIAL MILK; BLADDER CARCINOMA; CANCER PREVENTION; CANCER SCREENING; CHEMICAL CARCINOGENESIS; CHILD; CHILD NUTRITION; CHRONIC INFLAMMATION; DIET SUPPLEMENTATION; DIETARY INTAKE; FOOD AND DRUG ADMINISTRATION; FOOD CONTAMINATION; HEALTH HAZARD; HIGH RISK POPULATION; HUMAN; NEPHROTOXICITY; NONHUMAN; REVIEW; STONE FORMATION; URINARY TRACT TUMOR; UROLITHIASIS; UROTHELIUM;

ADULT; ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; CATTLE; CAUSALITY; COMORBIDITY; DIETARY SUPPLEMENTS; FATTY ACIDS, UNSATURATED; FEMALE; FOOD CONTAMINATION; HUMANS; INFANT; INFANT FORMULA; INFANT, NEWBORN; MALE; RATS; RISK ASSESSMENT; TRIAZINES; UROLITHIASIS; UROLOGIC NEOPLASMS;

EID: 84862582353     PISSN: 10590501     EISSN: 15324095     Source Type: Journal    
DOI: 10.1080/10590501.2012.684302     Document Type: Review

References (82)

1. Max D, Parkin MD, Bray F, Ferlay J, PisaniP. Global Cancer Statistics, 2002. A Cancer Journal for Clinicians. 2005;55:74-108.
2. Lewis SA. Everything you wanted to know about the bladder epithelium but were afraid to ask. American Journal of Physiology-Renal Physiology. 2000;278:867-874.
3. Zeegers MPA, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World Journal of Urology. 2004;392:401-421.
4. Xin H, Stone R. Tainted milk scandal: Chinese probe unmasks high-tech adulteration with melamine. Science. 2008;322:1310-1311. (Pubitemid 352775217)
5. Filigenzi MS, Puschner B, Aston LS, Poppenga RH. Diagnostic determination of melamine and related compounds in kidney tissue by liquid chromatography/tandem mass spectrometry. Journal of Agriculture Food Chemistry. 2008;56:75-79.
6. Bhalla V, Grimm PC, Chertow GM, Pao AC. Melamine nephrotoxicity: an emerging epidemic in an era of globalization. Kidney International. 2009;774:779-788.
7. Melnick RL, Boorman GA, Haseman JK, Montali RJ, Huff J. Urolithiasis and bladder carcinogenicity of melamine in 456 rodents. Toxicology and Applied Pharmacology. 1984;72:292-303.
8. Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid: Emerging mediators of inflammation. Prostaglandins Leukotrienes and Essential Fatty Acids. 2009;81:187-191.
9. Federico A, Morgillo F, Tuccillo C, Ciardiello F, Loguercio C. Chronic inflammation and oxidative stress in human carcinogenesis International Journal of Cancer. 2007;121:238-246.
10. Cremonezzi DC, Silva RA, del Pilar Díaz M, Valentich MA, Eynard AR. Dietary polyunsaturated fatty acids (PUFA) differentially modulate melamine-induced preneoplastic urothelial proliferation and apoptosis in mice. Prostaglandins Leukotrienes and Essential Fatty Acids. 2001;151:159-164.
11. Osborne CA, Lulich JP, Bartges JW, Ulrich LK, Koehler LA, Bird KA, Swanson LL, Austin GW, Prien EL Jr, Steinam KU. Drug-induced urolithiasis. The Veterinary Clinics of North America Small Animal Practice. 1999;29:251-266. (Pubitemid 29048770)
12. Chen YH, Liu HP, Chen HY, Tsai FJ, Chang CH, Lee YJ, Lin WY, Chen WC. Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis/urolithiasis. Kidney International. 2011;80:369-377.
13. Prieto RM, Fiol M, Perello J, Estruch R, Ros E, Sanchis P, Grases F. Effects of Mediterranean diets with low and high proportions of phytate-rich foods on the urinary phytate excretion. European Journal of Nutrition. 2010;49:321-326.
14. Pragasam V, Kalaiselvi P, Sumitra K, Srinivasan S, Varalakshmi P. Oral Larginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats. Clinica Chimica Acta. 2005;360:141-150. (Pubitemid 41225405)
15. Tan AC, Konczak I, Sze DM, Ramzan I. Molecular pathways for cancer chemoprevention by dietary phytochemicals. Nutrition and Cancer. 2011;63:495-505.
16. Spivacow FR, Negri AL, Polonsky A, Del Valle EE. Long-term treatment of renal lithiasis with potassium citrate. Urology. 2010;76:1346-1349.
17. Atmani F. Medical management of urolithiasis, what opportunity for phytotherapy? Frontiers in Bioscience. 2003;8:s507-514. (Pubitemid 39140177)
18. Yang J, An L, Yao Y, Yang Z, Zhang T. Melamine impairs spatial cognition and hippocampal synaptic plasticity by presynaptic inhibition of glutamatergic transmission in infant rats. Toxicology 2011;289:167-174.
19. Thompson ME, Lewis-Smith MR, Kalasinsky VF, Pizzolato KM, Fleetwood ML, McElhaneyMR, Johnson TO. Characterization of melamine-containing and calcium oxalate crystals in three dogs with suspected pet food-induced nephrotoxicosis. Veterinary Pathology. 2008;417:426-445.
20. Tyan YC, Yang MH, Jong SB, Wang CK, Shiea J. Melamine contamination. Analytical and Bioanalytical Chemistry. 2009;729:353-395.
21. Skinner CG, Thomas JD, Osterloh JD. Melamine toxicity. Journal of Medicine Toxicology. 2010;50:55-65.
22. Tittlemier SA. Methods for the analysis of melamine and related compounds in foods: a review. The Journal of AOAC International. 2010;129:452-457.
23. Cook HA, Klampfl CW, Buchberger W. Analysis of melamine resins by capillary zone electrophoresis with electrospray ionization-mass spectrometric detection. Electrophoresis. 2005;1576:1583-1626.
24. Wiwanitkit V. Melamine and its effect on coagulation system. Indian Journal of Hematology and Blood Transfusion. 2010;26:73-82.
25. Wei F, Lam R, Cheng S, Lu S, Ho D, Li N. Rapid detection of melamine in whole milk mediated by unmodified gold nanoparticles. Applied Physics Letters. 2010;29:96-702.
26. Andreatta MM, Muñoz SE, Lantieri MJ, Eynard AR, Navarro A. Artificial sweetener consumption and urinary tract tumors in Cordoba, Argentina. Preventive Medicine. 2008;136:139-147.
27. Eynard AR. Is the risk of urinary tract tumorigenesis enhanced by a marginal chronic essential fatty acid deficiency (EFAD)? Nutrition. 1998;211:216-314.
28. Eynard AR. Role of dietary polyunsaturated fatty acids (PUFA) on tumorigenesis. The Cancer Journal. 1996;142:144-149.
29. Apodaca G. The uroepithelium: not just a passive barrier. Traffic. 2004;117:128-135.
30. Monis B, Eynard AR. Incidence of urothelial tumors in rats deficient in essential fatty acids. Journal of the National Cancer Institute. 1980;64:73-79. (Pubitemid 10214284)
31. Higuchi T, Xin P, Buckley MS, Erickson DR, Bhavanandan VP. Characterization of the rabbit homolog of human MUC1glycoprotein isolated from bladder by affinity chromatography on immobilized jacalin. Glycobiology. 2000;10:659-667. (Pubitemid 30616201)
32. Karamouzis MV, Papavassiliou AG. Retinoid receptor cross-talking respiratory epithelium cancer chemoprevention. Trends in Molecular Medicine. 2005;1:10-16. (Pubitemid 40092669)
33. Esteller M. Epigenetics in cancer. New England Journal Medicine. 2008;358:1148-1159.
34. Ward JM, Uno H, Kurata Y, Weghorst CM, Jang JJ. Cell proliferation not associated with carcinogenesis in rodents and humans. Environment Health Perspective. 1993;5:125-135. (Pubitemid 24096337)
35. Álvarez Kindelán J, Campos Hernández JP, López Beltrán A, Requena Tapia MJ. Clasificación de la OMS 2004 para los tumores vesicales: Resumen y comentarios. Actas Urol Esp. 2007;31:978-998.
36. Keibel A, Singh V, Sharma MC. Inflammation, microenvironment, and the immune system in cancer progression. Current Pharmaceutical Design. 2009;15:1949-1955.
37. Yoshimoto A, Kasahara K, Kawashima A, Fujimura M, Nakao S. Characterization of the prostaglandin biosynthetic pathway in nonsmall cell lung cancer: a comparison with small cell lung cancer and correlation with angiogenesis, angiogenic factors and metastases. Oncology Report. 2005;1049:1057-1113.
38. Pasqualini ME, Berra MA, Calderón RO, Cremonezzi D, Giraudo C, Eynard AR. Dietary lipids modulate eicosanoid release and apoptosis of cells of a murine lung alveolar carcinoma. Prostaglandins Leukotrienes and Essential Fatty Acids. 2005;235:240-272.
39. Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutation Research. 2008;659:15-30.
40. Saigal CS, Joyce G, Timilsina AR. Urologic Diseases in America Project. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney International. 2005;1808:1814-1868.
41. Stapleton FB. Childhood stones. Endocrinology Metabolism Clinical of North America. 2002;1001:1015-1031.
42. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney International. 2003;1817:1823-1863.
43. Guan N, Fan Q, Ding J, Zhao Y, Lu J, Ai Y, Xu G, Zhu S, Yao C, Jiang L, Miao J, Zhang H, Zhao D, Liu X, Yao Y. Melamine-contaminated powdered formula and urolithiasis in young children New England Journal of Medicine. 2009;360:1067-1074.
44. Borghi L, Meschi T, Maggiore U, Prati B. Dietary therapy in idiopathic nephrolithiasis. Nutrition Reviewers. 2006;64:301-312. (Pubitemid 44124973)
45. Langman CB. Melamine, powdered milk, and nephrolithiasis in Chinese infants. New England Journal of Medicine. 2009;360:1139-1141.
46. Wang IJ, Chen PC, Hwang KC. Melamine and nephrolithiasis in children in Taiwan. New England Journal of Medicine. 2009;1157:1158-1360.
47. Ho SSY, Chu WCW, Wong KT, Li CK, Wong W, Ng PC, Ahuja A. Ultrasonographic evaluation of melamine-exposed children in Hong Kong. New England Journal of Medicine. 2009;1156:1157-1360.
48. American Institute for Cancer Research. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide [computer program]. Lyon: IARC Press; 2002.
49. Díaz MP, Osella AR, Aballay LR, Muñoz SE, Lantieri MJ, Butinof M, Paz RM, Pou S, Eynard AR, La Vecchia C. Cancer incidence pattern in Cordoba, Argentina. Eur J Cancer Prev. 2009;18:259-266.
50. Stewart BW, Kleihue P. World Cancer Report. Lyon: IARC Press; 2003.
51. Comba A, Lin YH, Eynard AR, Valentich MA, Fernandez-Zapico ME, Pasqualini ME. Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors. Cancer Metastasis Reviews 2011;Dec 30(3-4):325-342.
52. Bagnardi V, Blangiardo M, La Vecchia C, Corrao G. A meta-analysis of alcohol drinking and cancer risk. British Journal of Cancer. 2001;30:85-95.
53. Steinmaus CM, Nunez S, Smith AH. Diet and bladder cancer: a meta-analysis of six dietary variables. American Journal of Epidemiology. 2000;151:693-702. (Pubitemid 30463591)
54. Andreatta MM, Navarro A, Eynard AR. Urinary tract tumors, biology and risk for artificial sweeteners use with particular emphasis on some South American countries. Current Nutrition Food Science. 2008;185:195-204.
55. Langman CB, Alon U, Ingelfinger J, Englund M, Saland JM, Somers MJ, Stapleton FB, Sibú NO, Cochat P, Wong W, Eke FU, Satlin L, Salusky I. A position statement on kidney disease from powdered infant formula-based melamine exposure in Chinese infants. Pediatrics Nephrology. 2009;1263:1266-1324.
56. Ren FY, Wang Y, Hou XB, Zhang CR, Ma L. Clinical and imaging features in 16 infants exposed to food contaminated with melamine and cyanuric acid. American Journal of Roentgenology. 2009;192:707-710.
57. Sun N, Shen Y, Sun Q, Li XR, Jia LQ, Zhang GJ, Zhang WP, Chen Z, Fan JF, Jiang YP, Feng DC, Zhang RF, Zhu XY, Xiao HZ. Melamine related urinary calculus and acute renal failure in infants. Zhonghuaerkezazhi. 2008;46:810-815.
58. Sun N, Shen Y, Sun Q, Li XR, Jia LQ, Zhang GJ, Zhang WP, Chen Z, Fan JF, Jiang YP, Feng DC, Zhang RF, Zhu XY, Xiao HZ. Diagnosis and treatment of melamine-associated urinary calculus complicated with acute renal failure in infants and young children. Chinese Medical Journal. 2009;122:245-251.
59. Shen Y, Liu XR, Zhang GJ, Zhou N. Blood purification therapy in treatment of acute renal failure in infants with melamine-induced stones. Chinese Medical Journal. 2009;122:257-266.
60. Jia LQ, Shen Y, Wang XM, He LJ, Xin Y, Hu YX. Ultrasonographic diagnosis of urinary calculus caused by melamine in children. Chinese Medical Journal. 2009;122:252-256.
61. Lam CW, Lan L, Che X, Tam S, Wong SS, Chen Y, Jin J, Tao SH, Tang XM, Yuen KY, Tam PK. Diagnosis and spectrum of melamine-related renal disease: plausible mechanism of stone formation in humans Clinica Chemical Acta. 2009;402:450-455.
62. Zhu SL, Li JH, Chen L, Bao ZX, Zhang LJ, Li JP, Chen JH, Ji KM. Conservative management of pediatric nephrolithiasis caused by melamine-contaminated milk powder. Pediatrics. 2009;123:1099-1102.
63. Qiang S, Ying S, Ning S, GuiJu Z, Zhi C, Jian Feng F, Li QJ, Hong ZX, Xu RL, Puschner B. Diagnosis, treatment and follow-up of 25 patients with melamine-induced kidney stones complicated by acute obstructive renal failure in Beijing Children's Hospital. European Journal of Pediatrics. 2010;169;483-489.
64. Wen JG, Li ZZ, Zhang H, Wang Y, Zhang RF, Yang L, Chen Y, Wang JX, Zhang SJ. Melamine related bilateral renal calculi in 50 children: single center experience in clinical diagnosis and treatment. Journal of Urology. 2010;183:1533-1537.
65. Li G, Jiao S, Yin X, Deng Y, Pang X, Wang Y. The risk of melamine-induced nephrolithiasis in young children starts at a lower intake level than recommended by the WHO. Pediatrics Nephrology. 2010;25:135-141.
66. Yeh CC, Lin TH, Wu HC, Chang CH, Chen CC, Chen WC. A high association of upper urinary tract transitional cell carcinoma with nonfunctioning kidney caused by stone disease in Taiwan. Urologia Internacionalis. 2007;19:23-79.
67. Hau AK, Kwan TH, Li PK. Melamine toxicity and the kidney. Journal of the American Society of Nephrology. 2009;20:245-250.
68. Heck HD, Tyl RW. The induction of bladder stones by terephthalic acid, dimethyl terephthalate, and melamine (2,4,6-triamino-s-triazine) and its relevance to risk assessment. Regulatory Toxicology and Pharmacology. 1985;294:313-315.
69. Cremonezzi DC, Díaz MP, Valentich MA, Eynard AR. Neoplastic and preneoplastic lesions induced by melamine in rat urothelium are modulated by dietary polyunsaturated fatty acids. Food and Chemical Toxicology. 2004;1999:2007-2042.
70. Pou SA, Osella AR, Diaz MP. Bladder cancer mortality trends and patterns in Córdoba, Argentina (1986-2006). Cancer Causes Control. 2011;22:407-415.
71. Pou SA, Osella AR, Eynard AR, Diaz MP. Cancer mortality in Córdoba, Argentina, 1986-2006: an age-period-cohort analysis. Tumori. 2010;96:202-212.
72. Ogasawara H, Imaida K, Ishiwata H, Toyoda K, Kawanishi T, Uneyama C, Hayashi S, Takahashi M, Hayashi Y. Urinary bladder carcinogenesis induced by melamine in F344 male rats: correlation between carcinogenicity and urolithiasis formation. Carcinogenesis. 1995;16:2773-2777.
73. National Toxicology Program (NTP). Carcinogenesis bioassay of melamine (CAS No. 108-78-1) in F344/N rats and B6C3F1 mice (feed study). National Toxicology Program Technical Report Series. 1983;245:251-271.
74. Okumura M, Hasegawa R, Shirai T, Ito M, Yamada S, Fukushima S. Relationship between calculus formation and carcinogenesis in the urinary bladder of rats administered the non-genotoxicagents thymine or melamine. Carcinogenesis. 1992;1043:1513-1516.
75. Hu H, Sheng HQ, Ma XQ, Lai MD. Biological effects and toxicology studies of melamine and its derivative cyanuric acid. Zhejiang da xuexuebao. Yi xueba. Journal of Zhejiang University Medical Sciences. 2008;37:544-550.
76. Das UN. Essential fatty acids-a review. Current Pharmaceutical Biotechnology. 2006;467:482-487.
77. Spencer L, Mann C, Metcalfe M, Webb M, Pollard C, Spencer D, Berry D, Steward W, Dennison A. The effect of omega-3 FAs on tumour angiogenesis and their therapeutic potential. European Journal of Cancer. 2009;2077:2086-2145.
78. Das UN. Can essential fatty acids reduce the burden of disease(s)? Lipids in Health and Diseases. 2008;7:19.
79. Dain A, Repossi G, Das UN, Eynard AR. Role of PUFAs, the precursors of endocannabinoids, in human obesity and type 2 diabetes. Frontiers in Bioscience. 2010;2:1432-1447.
80. Espada CE, Berra MA, Martinez MJ, Eynard AR, Pasqualini ME. Effect of Chia oil (Salvia Hispanica) rich in omega-3 fatty acids on the eicosanoid release, apoptosis and T-lymphocyte tumor infiltration in a murine mammary gland adenocarcinoma. Prostaglandins Leukotrienes and Essential Fatty Acids. 2007;77:21-28. (Pubitemid 47260678)
81. Maloberti PM, Duarte AB, Orlando UD, Pasqualini ME, Solano AR, López-Otín C, Podestá EJ. Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells. PLoS One. 2010;5:e15540.
82. Das UN. Essential fatty acids: biochemistry, physiology, and pathology. Journal of Biotechnology. 2006;420:439-441.